Form 4: Tarsus Pharmaceuticals Director William J. Link Acquires Stock Options and Restricted Stock Units

William J. Link, a director at Tarsus Pharmaceuticals, was granted stock options and restricted stock units (RSUs) in connection with his service as a non-employee director.

Summary

• On June 13, 2024, William J. Link, a director of Tarsus Pharmaceuticals, received stock options to purchase 5,000 shares of common stock at an exercise price of $33.14.
• These options vest fully on the one-year anniversary of the grant date, contingent upon continuous service as a non-employee director.
• Additionally, Link was granted 3,350 restricted stock units (RSUs), each representing a contingent right to receive one share of Tarsus Pharmaceuticals' common stock.
• These RSUs also vest fully on the one-year anniversary of the grant date, subject to continuous service.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (granting of stock options and RSUs) which is generally viewed positively as it aligns director interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

This is a standard practice for compensating non-employee directors in publicly traded companies, aligning their interests with shareholders through equity ownership.

Comparison to Industry Standards

• Granting stock options and RSUs to directors is a common practice among publicly traded companies to incentivize performance and align interests with shareholders.
• The vesting period of one year is also fairly standard, encouraging continued service on the board.
• Comparable companies in the pharmaceutical industry, such as Alcon or Bausch + Lomb, often use similar equity-based compensation for their directors.

Stakeholder Impact

• The grant of equity to a director can positively impact shareholders by aligning management's interests with theirs.
• The director benefits from the potential increase in the company's stock value.

Key Dates